V CompBrief BY VELARION

Interim Chief Financial Officer · TENAX THERAPEUTICS, INC. (TENX)

Thomas McGauley

FY2025 is the first fiscal year CompBrief holds for Thomas McGauley as a named executive officer of TENAX THERAPEUTICS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$475,498

3rd of 3 named executive officers at Tenax Therapeutics by FY2025 total.

3 named officers on file for TENAX THERAPEUTICS, FY2025

See an example →

What this number hides

The filing gives the total. TENAX THERAPEUTICS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how TENAX THERAPEUTICS’s whole pay program stands against its peers

  • TENAX THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TENX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 22, 2026 (DEF 14A).

Free

Get Thomas McGauley’s full pay file as a PDF — free

More than this page: up to 10 years of Thomas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Thomas McGauley and every company like it: Velarion Intel, free for 3 days, no card →

Thomas McGauley compensation by year

TENAX THERAPEUTICS Summary Compensation Table · the one fiscal year held
In US dollars, as TENAX THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$0
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$475,498
Total$475,498

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TENAX THERAPEUTICS, INC. DEF 14A filed April 22, 2026, accession 0001193125-26-168580, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TENAX THERAPEUTICS, INC. filed document, accession 0001193125-26-168580. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.

TENAX THERAPEUTICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Christopher GiordanoPresident and Chief Executive Officer$8,079,633
Stuart RichChief Medical Officer$3,732,967
Thomas McGauley · this pageInterim Chief Financial Officer$475,498

Thomas McGauley's compensation dossier, TENAX THERAPEUTICS

You have read Thomas McGauley's totals and holdings. The dossier adds each equity grant TENAX THERAPEUTICS disclosed for Thomas McGauley and TENAX THERAPEUTICS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full TENAX THERAPEUTICS compensation record

free company brief
TENAX THERAPEUTICS, INC. (TENX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within TENAX THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order TENAX THERAPEUTICS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TENAX THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order TENX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Thomas McGauley's compensation dossier